Please assess the completion status of the following clinical trial:

Trial Title: Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who received Nexavar for unresectable or advanced renal cell carcinoma~Exclusion Criteria:~* Patients who are contraindicated based on the product label

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).